Skip to main content
. 2014 Oct 15;1(10):634–648. doi: 10.18632/oncoscience.87

Figure 2. Treatment of CAFs with combined cytokines or cancer cell-derived secretomes affects ECM protein expression.

Figure 2

(A) Western blot showing the effects of bFGF, EGF and TGF-β1 treatment (10 ng/ml) on the expression of biglycan, decorin, α-SMA and versican in CAFs. (B) Western blot illustrating the effects of treatment with cancer cell-derived conditioned medium (CM) on the expression of biglycan, decorin, α-SMA and versican in CAFs. TGF-β1 treatment (1 and 10 ng/ml) was included as a positive control. Tubulin was used as loading control (A, B).